New Zealand’s health regulator Medsafe has approved the paediatric Pfizer vaccine against Covid-19 for children of age 5 to 12 years, the health ministry said in a statement.

• Orient Cables Eyes Rs 3,500 Crore Revenue By FY30
• Bangladesh Resumes Indian Wheat Purchases as Black Sea Disruptions Lift Prices
• Central Railway Recovers Rs 140 Crore In Ticket Fines
• Cosmic CRF Unit Bags Rs 25.94 Crore Combined Orders
• Arivihan in Talks to Raise Rs 96 Crore at Rs 570 Crore Valuation

The temporary approval is for two doses of the paediatric Pfizer Covid-19 vaccine, which can be given in at least 21 days break, the statement said. If the cabinet approves the vaccine, the paediatric Pfizer vaccine will be started in New Zealand by the end of January 2022, the health ministry added.